| Yale University: New Synthetic Molecules Trigger Immune... |
|
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer... More »
|
|
Individual.com - Nov. 6, 2009
|
| Synthetic molecules trigger immune response to HIV |
|
Researchers at Yale Univ. have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer... More »
|
|
Research & Development - Nov. 6, 2009
|
| New Synthetic Molecules Trigger Immune Response to HIV... |
|
The molecules -- called 'antibody-recruiting molecule targeting HIV' (ARM-H) and 'antibody-recruiting molecule targeting prostate cancer' (ARM-P) -- work by binding... More »
|
|
POZ.com - Nov. 6, 2009
|
| Synthetic Molecules Trigger Immune Response To HIV,... |
|
Reers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer... More »
|
|
Red Orbit - Nov. 6, 2009
|
| New Synthetic Molecules Trigger Immune Response to HIV and... |
|
New Haven, Conn. - Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as... More »
|
|
WebWire - Nov. 6, 2009
|
| Site Announcements |
|
... ibody Antibody Antibody Antibody Antibody Antibody Antibody HSXToby Antibody Antibody Antibody Antibody Antibody Antibody Antibody Antibody StarBond Cashouts Antibody... More »
|
|
Hollywood Stock Exchange - Nov. 5, 2009
|
| Novel synthetic molecules boost immune response to HIV and... |
|
Synthetic molecules developed by researchers at Yale University could enhance the body's immune response to HIV and HIV-infected cells, and prostate cancer cells. The... More »
|
|
Sify - Nov. 6, 2009
|
| New findings may lead to novel therapeutic approaches for... |
|
New Haven, Conn.-Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as... More »
|
|
News-Medical.Net - Nov. 6, 2009
|